...
首页> 外文期刊>Geriatrics & gerontology international. >Taking metformin and cognitive function change in older patients with diabetes
【24h】

Taking metformin and cognitive function change in older patients with diabetes

机译:服用糖尿病患者的二甲双胍和认知功能变化

获取原文
获取原文并翻译 | 示例

摘要

Aim We investigated the effects of metformin on cognitive function in a prospective cohort of older adults. Methods Participants aged ≥60?years were selected, and their Korean version of the Consortium to Establish a Registry for Alzheimer's Diseases Assessment, including the Mini‐Mental State Examination, and activities of daily living were evaluated prospectively. Rapid deterioration of cognitive function was defined as annual change of test scores in the lowest quartile. Results A total of 732 participants (mean age 76.7?±?6.6?years) were followed up for 2.9?years (interquartile range 1.0–5.7?years). A linear mixed model showed that diabetes was associated with significant deterioration of Verbal Delayed Free Recall and Recognition scores ( P = 0.007 and 0.022, respectively). Among diabetes patients, metformin treatment was not associated with changes of any Korean version of the Consortium to Establish a Registry for Alzheimer's Diseases Assessment component or activities of daily living index. However, rapid deterioration of Mini‐Mental State Examination and Verbal Immediate Recall scores was more frequently found in the metformin‐taking group, even after adjustment for age, sex, education level, baseline cognitive function, baseline glycated hemoglobin levels, renal and liver function, body mass index, hypertension, dyslipidemia, antidiabetic agents other than metformin, and baseline brain imaging abnormality (odds ratio 4.47, 95% confidence interval 1.24–16.05 and odds ratio 7.37, 95% confidence interval 1.19–45.56). Conclusions Metformin treatment was not associated with changes of any of Korean version of the Consortium to Establish a Registry for Alzheimer's Diseases Assessment component scores or activities of daily living index. However, rapid deterioration of Mini‐Mental State Examination and Verbal Immediate Recall scores was more frequently found in the metformin‐treated group. Geriatr Gerontol Int 2019; 19: 755–761 .
机译:目的我们研究了二甲双胍对老年人预期队列中的认知功能的影响。方法≥60岁的参与者被选中,并朝向阿尔茨海默氏症疾病评估设立注册表,包括迷你精神状态审查和日常生活活动,以及日常生活活动的韩国公司。认知功能的快速恶化被定义为最低四分位数的测试评分的年度变化。结果共有732名参与者(平均年龄为76.7?±6.6岁?年)2.9?年(四分位数1.0-5.7?年)。线性混合模型表明,糖尿病与言语延迟的自由召回和识别评分的显着恶化有关(P = 0.007和0.022)。在糖尿病患者中,二甲双胍治疗与联盟的任何韩国版的变化无关,以建立阿尔茨海默氏症的疾病评估组成部分或日常生活指数活动的登记。然而,在二甲双胍的群体中,更常见的迷你精神状态检查和口头立即召回评分的快速恶化,即使在调整年龄,性别,教育水平,基线认知功能,基线糖化血红蛋白水平,肾和肝功能时,也甚至在调整后更常见。 ,体重指数,高血压,血脂血症,二甲双胍以外的抗糖尿病药物,基线脑成像异常(差距为4.47,95%置信区间1.24-16.05和差距7.37,95%置信区间1.19-45.56)。结论二甲双胍治疗与韩国版本的任何联盟的变化无关,以建立阿尔茨海默氏症的疾病评估组成部分或日常生活指数活动的注册表。然而,在二甲双胍治疗组中更常见地发现迷你精神状态检查和口头立即召回评分的快速恶化。 GeriaTr Gerontol int 2019; 19:755-761。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号